Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No Adverse event; HCP states that they administered 16 shots to patients after their expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP states that they administered 16 shots to patients after their expiration date) and NO ADVERSE EVENT (No Adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 048L21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 12-Apr-2022,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP states that they administered 16 shots to patients after their expiration date). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP states that they administered 16 shots to patients after their expiration date) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (HCP states that they administered 16 shots to patients after their expiration date).    It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was unknown if patient had any relevant medical history conditions, allergy, concomitant diseases and risk factor. No concomitant medication was reported.  Suspect product dosage text was reported as unknown. The intact cartons of 0.5 ml of were initially stored in the refrigerator and the thaw dates were the same as administration dates as 01-Sep-2022 ,25-Aug-2022, 04-Aug-2022, 26-Jul-2022 and 19-Jul-2022. The vial did not undergo any temperature excursions. No treatment medication was reported. This case is reported for patient 1st out of 16 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-739843, US-MODERNATX, INC.-MOD-2023-739848, US-MODERNATX, INC.-MOD-2023-739857, US-MODERNATX, INC.-MOD-2023-739859, US-MODERNATX, INC.-MOD-2023-739861, US-MODERNATX, INC.-MOD-2023-739862, US-MODERNATX, INC.-MOD-2023-739864, US-MODERNATX, INC.-MOD-2023-739863, US-MODERNATX, INC.-MOD-2023-739867, US-MODERNATX, INC.-MOD-2023-739868, US-MODERNATX, INC.-MOD-2023-739839, US-MODERNATX, INC.-MOD-2023-739851 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-739843:Patient 5 US-MODERNATX, INC.-MOD-2023-739848:Patient 7 US-MODERNATX, INC.-MOD-2023-739857:Patient 12 US-MODERNATX, INC.-MOD-2023-739867:Patient 10 US-MODERNATX, INC.-MOD-2023-739868:Patient 11 US-MODERNATX, INC.-MOD-2023-739861:Patient 14 US-MODERNATX, INC.-MOD-2023-739864:Patient 9 US-MODERNATX, INC.-MOD-2023-739863:Patient 16 US-MODERNATX, INC.-MOD-2023-739862:Patient 15 US-MODERNATX, INC.-MOD-2023-739859:Patient 13 US-MODERNATX, INC.-MOD-2023-739839:Patient 4 US-MODERNATX, INC.-MOD-2023-739851:Patient 8